Trial Profile
A study investigating the weight and glucose reducing effect of Liraglutide in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jan 2016
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 12 Jan 2016 New trial record